🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and pharmacokinetics...
Status
Completed
Location
The medical facility selected by Taisho Pharmaceutical Co., Ltd
Start Date
2015-10-17
Trial ID
NCT04169893
Multicenter, randomized, placebo-controlled, 4-arm, 4-period crossover doub...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2017-07-07
Trial ID
NCT04573725
Treatments Being Tested
A study to evaluate the respiratory safety of TS-142 in patients with mild ...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2021-02-24
Trial ID
NCT04746105
Treatments Being Tested
A clinical study to evaluate the residual effects of TS-142 on driving perf...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2021-01-16
Trial ID
NCT04696952
The purpose of this study is to investigate the safety, pharmacokinetics, a...
Status
Completed
Location
The medical facility selected by Taisho Pharmaceutical Co., Ltd
Start Date
2016-07-06
Trial ID
NCT04169906
Treatments Being Tested
This is a study to investigate the next-day residual effects of a single be...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2023-05-15
Trial ID
NCT05819710
A clinical study to evaluate the effects on QT/QTc Interval of TS-142 in He...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2021-06-07
Trial ID
NCT04873323
Treatments Being Tested
This is a randomized, double-blind, multi-center, placebo-controlled, paral...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2022-08-30
Trial ID
NCT05453136
Treatments Being Tested
This is a study to evaluate the safety, tolerability, and pharmacokinetics ...
Status
Completed
Location
PPD Phase I unit
Start Date
2020-09-14
Trial ID
NCT04464239
Treatments Being Tested
The purpose of this study is to investigate the safety, pharmacokinetics, a...
Status
Completed
Location
Sumida Hospital
Start Date
2019-09-17
Trial ID
NCT04087707
Treatments Being Tested